CDC weighs risk of BA.2.86 COVID-19 lineage

CDC weighs risk of BA.2.86 COVID-19 lineage

The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and...
COVID-19 vax lowers severity, mortality post infection

COVID-19 vax lowers severity, mortality post infection

In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2. The study published in The Lancet Microbe found among individuals recently infected with...
Bivalent COVID booster better than 1-strain 4th dose

Bivalent COVID booster better than 1-strain 4th dose

CREDIT: NIH/NIAID cc A fourth dose of the bivalent (two-strain) COVID-19 vaccine is substantially more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected people who...
Study finds new way to stop excess COVID inflammation

Study finds new way to stop excess COVID inflammation

By Maria Fernanda Ziegler  |  Agência FAPESP – Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune...